Publication date: 15 December 2026 Source: The American Journal of Cardiology, Volume 281 Author(s): Ibrahim Mortada, Aaron W. Lee, Dalton Buckingham, Grant Ebel, Nicholas Long, Jayasurya Dileep, Avinav Sanjel, Ali Al-Shammari, Thomas A. Blackwell, Hani Jneid
Comparative Cardiovascular Outcomes Associated With Evolocumab Versus Inclisiran Among Patients With Elevated Lipoprotein(a). // The American Journal of Cardiology. – URL: https://www.sciencedirect.com/science/article/pii/S0002914926006314?dgcid=rss_sd_all
Comparative Cardiovascular Outcomes Associated With Evolocumab Versus Inclisiran Among Patients With Elevated Lipoprotein(a). The American Journal of Cardiology. https://www.sciencedirect.com/science/article/pii/S0002914926006314?dgcid=rss_sd_all
“Comparative Cardiovascular Outcomes Associated With Evolocumab Versus Inclisiran Among Patients With Elevated Lipoprotein(a).” The American Journal of Cardiology.
@article{article67107,
title = {Comparative Cardiovascular Outcomes Associated With Evolocumab Versus Inclisiran Among Patients With Elevated Lipoprotein(a)},
journal = {The American Journal of Cardiology},
url = {https://www.sciencedirect.com/science/article/pii/S0002914926006314?dgcid=rss_sd_all}
}